X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.prnewswire.com/news-releases/indivior-announces-publication-demonstrating-that-opvee-nalmefene-nasal-spray-rapidly-reverses-effects-of-opioid-induced-respiratory-depression-in-head-to-head-study-against-intranasal-naloxone-302085667.html
https://endpts.com/fda-approves-another-new-type-of-opioid-overdose-antidote-nasal-spray/
https://www.prnewswire.com/news-releases/indivior-announces-us-food-and-drug-administration-approval-of-opvee-nalmefene-nasal-spray-an-opioid-overdose-rescue-medicine-for-natural-and-synthetic-opioids-like-fentanyl-301831447.html
https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-fda-clearance-of-ind-application-for-nalmefene-implant-301580339.html
https://www.globenewswire.com/news-release/2022/06/08/2459192/37234/en/Opiant-Pharmaceuticals-and-Aptar-Pharma-Expand-Long-Term-Collaboration-for-the-Manufacture-of-Unidose-Nasal-Spray-for-OPNT003-Nasal-Nalmefene.html
https://www.globenewswire.com/news-release/2022/04/27/2430661/37234/en/Opiant-Pharmaceuticals-Announces-Positive-Topline-Results-from-Head-to-Head-Pharmacodynamic-Study-Comparing-OPNT003-Nasal-Nalmefene-to-Nasal-Naloxone.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212955
https://www.businesswire.com/news/home/20210610005182/en/FDA-Accepts-Filing-of-Abbreviated-New-Drug-Application-and-Grants-Priority-Review-for-Nalmefene-HCI-Injection-for-the-Treatment-of-Known-or-Suspected-Opioid-Overdose
https://www.globenewswire.com/news-release/2020/10/29/2117345/0/en/Opiant-Pharmaceuticals-Partners-with-Aptar-Pharma-for-Nasal-Nalmefene-Opioid-Overdose-Treatment.html
https://www.prnewswire.com/news-releases/positive-results-from-human-pk-study-assessing-orexos-intranasal-nalmefene-formulations-for-opioid-overdose-reversal-301085604.html
https://www.raps.org/news-and-articles/news-articles/2019/7/fda-to-speed-review-of-generic-versions-of-opioid?feed=Regulatory-Focus
https://www.businesswire.com/news/home/20190424005220/en/FDA-Grants-Competitive-Generic-Therapy-CGT-Designation/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
http://www.pharmafile.com/news/520452/purdue-pharma-vow-not-profit-fast-tracked-opioid-overdose-antidote
https://www.businesswire.com/news/home/20190313005232/en/FDA-Grants-Purdue-Pharma%E2%80%99s-Nalmefene-HCl-Injection/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.biocentury.com/bc-extra/company-news/2018-09-20/opiant-gets-barda-grant-intranasal-opioid-antagonist
https://www.prnewswire.com/news-releases/titan-awarded-nida-grant-for-the-development-of-a-nalmefene-implant-for-the-prevention-of-opioid-addiction-relapse-300709420.html
https://www.federalregister.gov/documents/2017/11/03/2017-23952/determination-that-revex-nalmefene-hydrochloride-injection-01-milligram-basemilliliter-and-10
http://www.biotie.com/investors/releases/pr-story.aspx?ResultPageURL=http://cws.huginonline.com/B/132030/PR/201501/1890574.xml
Market Place
Share 
